The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Breast Cancer Res. 2016 Nov 9;18(1):111. doi: 10.1186/s13058-016-0762-9.

¹ IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, via Adamello 16, 20139, Milan, Italy. irene.catucci@ifom.eu.
² Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
³ Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
⁴ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Victoria, Australia.
⁵ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
⁶ Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Australia.
⁷ IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, via Adamello 16, 20139, Milan, Italy.

No abstract available

Keywords: Breast cancer genetic risk factor; Breast cancer predisposition; PALB2 p.Leu939Trp; VUS.

Publication types